Timely referral for device-aided therapy in Parkinson?s disease. Development of a screening tool

Background: Timely referral of Parkinson's disease (PD) patients to specialized centers for treatment with device -aided therapies (DAT) is suboptimal.Objective: To develop a screening tool for timely referral for DAT in PD and to compare the tool with the pub-lished 5-2-1 criteria. Methods: A cross-sectional, observational study was performed in 8 hospitals in the catchment area of a specialized movement disorder center in the Northern part of the Netherlands. The target population comprised PD patients not yet on DAT visiting the outpatient clinic of participating hospitals. The primary outcome was apparent eligibility for referral for DAT based on consensus by a panel of 5 experts in the field of DAT. Multi -variable logistic regression modelling was used to develop a screening tool for eligibility for referral for DAT. Potential predictors were patient and disease characteristics as observed by attending neurologists.Results: In total, 259 consecutive PD patients were included, of whom 17 were deemed eligible for referral for DAT (point prevalence: 6.6%). Presence of response fluctuations and troublesome dyskinesias were the strongest independent predictors of being considered eligible. Both variables were included in the final model, as well as levodopa equivalent daily dose. Decision curve analysis revealed the new model outperforms the 5-2-1 criteria. A simple chart was constructed to provide guidance for referral. Discrimination of this simplified scoring system proved excellent (AUC after bootstrapping: 0.97). Conclusions: Awaiting external validation, the developed screening tool already appears promising for timely referral and subsequent treatment with DAT in patients with PD.

Automated summary

This study aimed to develop a screening tool for timely referral of Parkinson's disease (PD) patients to specialized centers for treatment with device-aided therapies (DAT) and compared it with the published 5-2-1 criteria. By conducting a cross-sectional study in 8 hospitals in the Netherlands, the researchers developed a screening tool based on patient and disease characteristics to determine eligibility for referral for DAT in PD patients.